Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹?TP). The ...
The new brand, named after a mythological Swiss animal, combines celestial symbolism and tarot with the technical rigour of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback